Australia has benefited enormously from innovations enabled by the commercial scale and investment capacity of the US healthcare market. Yet the debate in Australia often reflects an incomplete understanding of how that market works and its core strengths beyond a capacity to innovate. …
Australia, the US, and their different choices about health system trade-offs
April 17, 2026 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Mark Butler confirms new and expanded cancer medicine listings
April 17, 2026 - - Latest News -
Why hospitals, and not medicines, dominate America’s health spending gap
April 17, 2026 - - Latest News -
Australia, the US, and their different choices about health system trade-offs
April 17, 2026 - - Latest News -
New strategic alliance for Biointelect aims to fast track life sciences innovation
April 17, 2026 - - Latest News -
Why US health spending looks much higher than it really is
April 16, 2026 - - Latest News -
Pharmacy prescribing reform signals shift in NSW primary care with Victoria to follow
April 15, 2026 - - Latest News -
Noxopharm appoints Dr Olivier Laczka as CEO to lead next phase of growth
April 15, 2026 - - Australian Biotech